BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37236713)

  • 1. Collagen Vascular Diseases: A Review of Cutaneous and Systemic Lupus Erythematosus, Dermatomyositis, and Distinguishing Features in Skin of Color.
    Lee V; Sokumbi O; Onajin O
    Dermatol Clin; 2023 Jul; 41(3):435-454. PubMed ID: 37236713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen vascular diseases.
    Callen JP
    J Am Acad Dermatol; 2004 Sep; 51(3):427-39. PubMed ID: 15337987
    [No Abstract]   [Full Text] [Related]  

  • 3. Recognition and Management of Cutaneous Connective Tissue Diseases.
    Kus KJB; LaChance AH; Vleugels RA
    Med Clin North Am; 2021 Jul; 105(4):757-782. PubMed ID: 34059249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing subacute cutaneous from other types of lupus erythematosus.
    McCauliffe DP
    Lancet; 1998 May; 351(9115):1527-8. PubMed ID: 10326532
    [No Abstract]   [Full Text] [Related]  

  • 5. The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis.
    Magro CM; Segal JP; Crowson AN; Chadwick P
    J Cutan Pathol; 2010 Jun; 37(6):659-71. PubMed ID: 19891658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in disease activity needed for meaningful change in cutaneous lupus by patient characteristic: A retrospective analysis of a longitudinal database.
    Kleitsch J; Pandya R; Chakka S; Yan D; Lim D; Diaz D; Feng R; Werth VP
    J Am Acad Dermatol; 2024 Feb; 90(2):406-408. PubMed ID: 37806526
    [No Abstract]   [Full Text] [Related]  

  • 7. Lupus erythematosus. Histopathology of cutaneous lesions.
    Clark WH; Reed RJ; Mihm MC
    Hum Pathol; 1973 Jun; 4(2):157-63. PubMed ID: 4706177
    [No Abstract]   [Full Text] [Related]  

  • 8. Photosensitivity in collagen vascular diseases.
    Callen JP
    Semin Cutan Med Surg; 1999 Dec; 18(4):293-6. PubMed ID: 10604795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
    Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
    Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects.
    Dourmishev L; Meffert H; Piazena H
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):230-4. PubMed ID: 15379871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lupus erythematosus].
    Goerz G; Lehmann P; Schuppe HC; Lakomek HJ; Kind P
    Z Hautkr; 1990 Mar; 65(3):226, 229-34. PubMed ID: 2339576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoid drug-induced lupus erythematosus induced by antitumor necrosis factor agents is a very rare subtype of cutaneous lupus: Three cases and literature review.
    Brehon A; Moguelet P; Guégan S; Abisror N; Barbaud A; Beal C; Laffitte E; Fain O; Francès C; Chasset F
    Dermatol Ther; 2020 May; 33(3):e13364. PubMed ID: 32239589
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cutaneous lesions in lupus erythematosus].
    Wenzel J; Tüting T; Bieber T
    Dtsch Med Wochenschr; 2003 Aug; 128(31-32):1655-8. PubMed ID: 12894393
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor necrosis factor α release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients.
    Nabatian AS; Bashir MM; Wysocka M; Sharma M; Werth VP
    Arthritis Res Ther; 2012 Jan; 14(1):R1. PubMed ID: 22217359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chilblain lupus erythematosus associated with systemic and discoid lupus erythematosus.
    Cardenas-de la Garza JA; Arvizu-Rivera RI; Ocampo-Candiani J; Galarza-Delgado DA
    Rheumatology (Oxford); 2021 Feb; 60(2):988. PubMed ID: 32856084
    [No Abstract]   [Full Text] [Related]  

  • 16. The involvement of galectin-3 in skin injury in systemic lupus erythematosus patients.
    Shi Z; Meng Z; Han Y; Cao C; Tan G; Wang L
    Lupus; 2018 Apr; 27(4):621-627. PubMed ID: 29058991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin CD4
    Zhao Z; Zhu H; Li Q; Liao W; Chen K; Yang M; Long D; He Z; Zhao M; Wu H; Lu Q
    J Autoimmun; 2022 Apr; 128():102811. PubMed ID: 35278775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients.
    Tebbe B; Mansmann U; Wollina U; Auer-Grumbach P; Licht-Mbalyohere A; Arensmeier M; Orfanos CE
    Acta Derm Venereol; 1997 Jul; 77(4):305-8. PubMed ID: 9228225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study.
    Olbrich H; Kridin K; Zirpel H; Sadik CD; Terheyden P; Thaçi D; Ludwig RJ; Boch K
    EBioMedicine; 2023 Jul; 93():104639. PubMed ID: 37285617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects.
    Vale ECSD; Garcia LC
    An Bras Dermatol; 2023; 98(3):355-372. PubMed ID: 36868923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.